AXIM Biotechnologies Inc (AXIM)
OTHER OTC:AXIM
US Market
Holding AXIM?
Track your performance easily

AXIM Biotechnologies (AXIM) Financial Statements

151 Followers

AXIM Biotechnologies Financial Overview

AXIM Biotechnologies's market cap is currently ―. The company's EPS TTM is $-0.016; its P/E ratio is -0.68; AXIM Biotechnologies is scheduled to report earnings on March 19, 2018, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 17.48K$ 52.98K$ 12.61K$ 9.58K$ 9.93K
Gross Profit$ 15.73K$ 52.98K$ 12.61K$ 9.58K$ 9.93K
EBIT$ -2.09M$ -590.11K$ -2.62M$ 442.95K$ -2.97M
EBITDA$ -1.92M$ -422.54K$ -2.46M$ 549.70K$ -2.82M
Net Income Common Stockholders$ -2.27M$ -292.30K$ -1.90M$ 328.47K$ -3.72M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 0.00$ 0.00$ 0.00$ 23.22K$ 97.50K
Total Assets$ 3.73M$ 3.93M$ 4.12M$ 4.04M$ 4.25M
Total Debt$ 5.22M$ 5.17M$ 5.89M$ 4.22M$ 4.17M
Net Debt$ 5.22M$ 5.17M$ 5.89M$ 4.20M$ 4.08M
Total Liabilities$ 13.26M$ 11.38M$ 11.78M$ 10.00M$ 14.00M
Stockholders Equity$ -9.53M$ -7.45M$ -7.66M$ -5.96M$ -9.75M
Cash Flow-
Free Cash Flow$ 553.01K$ -1.07M$ 19.56K$ -264.50K$ -643.59K
Operating Cash Flow$ 553.01K$ -1.07M$ 19.56K$ -264.50K$ -643.59K
Investing Cash Flow-$ -2.84K---
Financing Cash Flow$ -643.68K$ 1.01M$ 113.68K$ 190.22K$ 687.55K
Currency in USD

AXIM Biotechnologies Earnings and Revenue History

AXIM Biotechnologies Debt to Assets

AXIM Biotechnologies Cash Flow

AXIM Biotechnologies Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis